These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21730264)
1. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma. Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules. Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584 [TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814 [TBL] [Abstract][Full Text] [Related]
4. Distinct expression of Survivin splice variants in breast carcinomas. Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334 [TBL] [Abstract][Full Text] [Related]
5. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas. Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755 [TBL] [Abstract][Full Text] [Related]
6. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients. Taubert H; Kappler M; Bache M; Bartel F; Köhler T; Lautenschläger C; Blümke K; Würl P; Schmidt H; Meye A; Hauptmann S Oncogene; 2005 Aug; 24(33):5258-61. PubMed ID: 15856009 [TBL] [Abstract][Full Text] [Related]
8. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753 [TBL] [Abstract][Full Text] [Related]
9. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants. Marioni G; Agostini M; Bedin C; Blandamura S; Stellini E; Favero G; Lionello M; Giacomelli L; Burti S; D'Angelo E; Nitti D; Staffieri A; De Filippis C Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma. Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540 [TBL] [Abstract][Full Text] [Related]
11. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908 [TBL] [Abstract][Full Text] [Related]
12. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Zhi F; Chen X; Wang S; Xia X; Shi Y; Guan W; Shao N; Qu H; Yang C; Zhang Y; Wang Q; Wang R; Zen K; Zhang CY; Zhang J; Yang Y Eur J Cancer; 2010 Jun; 46(9):1640-9. PubMed ID: 20219352 [TBL] [Abstract][Full Text] [Related]
13. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia. Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905 [TBL] [Abstract][Full Text] [Related]
15. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland. Liao Y; Zeng H; Wang X; Huang Y; Chen N; Ge B; Tang L; Luo Q Exp Eye Res; 2009 Jan; 88(1):4-11. PubMed ID: 18955046 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer. Atlasi Y; Mowla SJ; Ziaee SA Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors. Malakootian M; Mowla SJ; Saberi H; Asadi MH; Atlasi Y; Shafaroudi AM Mol Carcinog; 2010 Sep; 49(9):818-25. PubMed ID: 20572164 [TBL] [Abstract][Full Text] [Related]
18. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis. Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue. Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749 [TBL] [Abstract][Full Text] [Related]
20. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]